Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Radionetics Oncology
AddedFeb 17, 2024
UpdatedJun 18, 2026
Radionetics Oncology

Radionetics Oncology

Series A

Radionetics Oncology: Innovating novel radiotherapeutics for diverse oncology treatments.

HQ
San Diego, CA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Radionetics Oncology is a pharmaceutical company dedicated to developing innovative radiotherapeutics for oncology treatments. The firm focuses on discovering and advancing novel radiopharmaceuticals, a class of precision oncology medicines, to address a wide range of cancer indications. Radionetics aims to transform cancer treatment by harnessing the power of radiopharmaceuticals in a new era of precision medicine.

The company has successfully raised a Series A funding round to advance its first-in-class radiopharmaceutical pipeline. Paul Grayson, an industry leader, has been appointed as CEO, bringing valuable experience to guide Radionetics in its mission. The firm is committed to making a difference in cancer treatment, combining scientific expertise with a dedication to improving patient outcomes.

Radionetics Oncology - Similar Companies

Nucleus RadioPharma logo

Nucleus RadioPharma

nucleusrad.com

Mariana Oncology logo

Mariana Oncology

Aktis Oncology logo

Aktis Oncology

aktisoncology.com

Illumina Radiopharmaceuticals logo

Illumina Radiopharmaceuticals

Radiomedix logo

Radiomedix

radiomedix.com

RadioRx logo

RadioRx

radiorx.com

Oncurie logo

Oncurie

oncurie.com

Ratio Therapeutics logo

Ratio Therapeutics

ratiotx.com

Radialogica logo

Radialogica

radialogica.com

Core Oncology logo

Core Oncology

Radimmune Therapeutics logo

Radimmune Therapeutics

NuView Life Sciences logo

NuView Life Sciences

Radiology Partners logo

Radiology Partners

radpartners.com

Oncospace logo

Oncospace

oncospace.com

RAD AI logo

RAD AI

radai.com

Radionetics Oncology - Quick Facts

Who are Radionetics Oncology's competitors?

Companies similar to Radionetics Oncology include Nucleus RadioPharma, Mariana Oncology, Aktis Oncology and Illumina Radiopharmaceuticals.

When was Radionetics Oncology founded?

Radionetics Oncology was founded in 2021.

Where is Radionetics Oncology's headquarters located?

Radionetics Oncology's headquarters is located in San Diego, CA, US.

When was Radionetics Oncology's last funding round?

Radionetics Oncology's most recent funding round was for $52.5M (USD) in August 2023.

How much has Radionetics Oncology raised to-date?

As of Aug 14, 2023, Radionetics Oncology has raised a total of $82.5M (USD).

How many employees does Radionetics Oncology have?

Radionetics Oncology has 20 employees as of Feb 5, 2024.

Radionetics Oncology - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Radiopharmaceuticals
Tags
  • Data Information
  • Healthcare
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 19 more industry codes
NAICS
  • 456000Health and Personal Care Retailers
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 450000Retail Trade
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 456100Health and Personal Care Retailers
  • 541700Scientific Research and Development Services
  • 456110Pharmacies and Drug Retailers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 5900Miscellaneous Retail
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 5910Drug Stores And Proprietary Stores
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research